SciVision Biotech Inc. (TPE:1786)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
65.20
+0.20 (0.31%)
At close: Mar 27, 2026

SciVision Biotech Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4,8795,2417,4665,2543,5873,283
Market Cap Growth
-44.97%-29.80%42.10%46.46%9.27%-12.78%
Enterprise Value
4,4384,7676,9084,9363,0753,197
Last Close Price
65.2072.60100.4673.3850.1944.30
PE Ratio
29.9332.2830.8229.5425.3232.28
PS Ratio
5.505.918.457.376.446.49
PB Ratio
2.462.653.943.232.372.26
P/TBV Ratio
2.472.653.943.242.382.27
P/FCF Ratio
217.19233.3231.7620.4221.4845.14
P/OCF Ratio
39.3542.2727.6719.3219.7133.33
EV/Sales Ratio
5.015.387.826.925.526.32
EV/EBITDA Ratio
16.4218.3322.2718.8815.7418.47
EV/EBIT Ratio
23.3725.1027.8424.7222.8526.22
EV/FCF Ratio
197.58212.2229.3819.1818.4143.95
Debt / Equity Ratio
0.250.250.120.210.270.44
Debt / EBITDA Ratio
1.791.790.721.322.103.62
Debt / FCF Ratio
21.6021.600.951.352.478.70
Net Debt / Equity Ratio
-0.22-0.22-0.31-0.24-0.14-0.04
Net Debt / EBITDA Ratio
-1.69-1.69-1.87-1.52-1.05-0.36
Net Debt / FCF Ratio
-19.61-19.61-2.47-1.54-1.23-0.86
Asset Turnover
0.350.350.390.340.260.24
Inventory Turnover
3.223.222.862.192.082.54
Quick Ratio
6.706.702.915.805.541.82
Current Ratio
8.178.173.466.926.882.17
Return on Equity (ROE)
8.37%8.37%13.75%11.34%9.57%7.13%
Return on Assets (ROA)
4.72%4.72%6.87%5.86%3.86%3.67%
Return on Invested Capital (ROIC)
11.16%11.67%16.20%13.35%8.16%7.92%
Return on Capital Employed (ROCE)
7.60%7.60%12.30%9.90%6.80%6.60%
Earnings Yield
3.33%3.10%3.25%3.39%3.95%3.10%
FCF Yield
0.46%0.43%3.15%4.90%4.66%2.21%
Dividend Yield
4.98%-3.23%3.41%3.98%3.21%
Payout Ratio
144.06%144.06%69.90%74.93%66.21%57.57%
Buyback Yield / Dilution
-3.33%-3.33%2.58%-2.39%-5.18%-0.61%
Total Shareholder Return
1.65%-3.33%5.82%1.02%-1.20%2.59%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.